This is a Validated Antibody Database (VAD) review about human SREBP-1, based on 46 published articles (read how Labome selects the articles), using SREBP-1 antibody in all methods. It is aimed to help Labome visitors find the most suited SREBP-1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SREBP-1 synonym: SREBP1; bHLHd1

Knockout validation
Novus Biologicals
mouse monoclonal (2A4)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1c
Novus Biologicals SREBP-1 antibody (Novus, NB600-582) was used in western blot knockout validation on human samples at 1:1000 (fig 1c). Front Pharmacol (2019) ncbi
BD Biosciences
mouse monoclonal (IgG-2A4)
  • western blot knockout validation; mouse; 1:1000; fig s6
BD Biosciences SREBP-1 antibody (BD Biosciences, 557036) was used in western blot knockout validation on mouse samples at 1:1000 (fig s6). Nat Commun (2016) ncbi
Santa Cruz Biotechnology
mouse monoclonal (2A4)
  • western blot; mouse; loading ...; fig 4a
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, sc13551) was used in western blot on mouse samples (fig 4a). Mol Metab (2022) ncbi
mouse monoclonal (2A4)
  • western blot; mouse; 1:400; loading ...; fig 6b
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, sc-13551) was used in western blot on mouse samples at 1:400 (fig 6b). Cell Death Dis (2021) ncbi
mouse monoclonal (A-4)
  • western blot; mouse; 1:1000; loading ...; fig s1a
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, sc-365513) was used in western blot on mouse samples at 1:1000 (fig s1a). J Inflamm Res (2021) ncbi
mouse monoclonal (F-10)
  • western blot; mouse; 1:1000; loading ...; fig 4a, 4c
  • western blot; human; 1:1000; loading ...; fig 4d
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, sc-365514) was used in western blot on mouse samples at 1:1000 (fig 4a, 4c) and in western blot on human samples at 1:1000 (fig 4d). Nat Commun (2021) ncbi
mouse monoclonal (A-4)
  • western blot; mouse; loading ...; fig 3d
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, sc-365513) was used in western blot on mouse samples (fig 3d). Sci Rep (2020) ncbi
mouse monoclonal (2A4)
  • western blot; mouse; loading ...; fig 3d
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz Biotechnology (Santa Cruz, CA), sc-13551) was used in western blot on mouse samples (fig 3d). Pharmacol Res (2020) ncbi
mouse monoclonal (2A4)
  • western blot; mouse; loading ...; fig 1b, e1e
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, sc-13551) was used in western blot on mouse samples (fig 1b, e1e). EMBO J (2019) ncbi
mouse monoclonal (2A4)
  • western blot; human; loading ...; fig 1c, s5c
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, 2A4) was used in western blot on human samples (fig 1c, s5c). Clin Sci (Lond) (2019) ncbi
mouse monoclonal (2A4)
  • western blot; human; loading ...; fig 6b
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, sc-13551) was used in western blot on human samples (fig 6b). FEBS Lett (2018) ncbi
mouse monoclonal (2A4)
  • western blot; mouse; fig 2b
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, sc-13551) was used in western blot on mouse samples (fig 2b). J Lipid Res (2016) ncbi
mouse monoclonal (2A4)
  • western blot; mouse; 1:1000; fig 6
  • RNA immunoprecipitation; human; 1:50; fig 4
  • western blot; human; 1:1000; fig 5
Santa Cruz Biotechnology SREBP-1 antibody (santa Cruz, sc-13551) was used in western blot on mouse samples at 1:1000 (fig 6), in RNA immunoprecipitation on human samples at 1:50 (fig 4) and in western blot on human samples at 1:1000 (fig 5). Sci Rep (2016) ncbi
mouse monoclonal (A-4)
  • western blot; bovine; fig 1
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz Biotechnology, sc-365513) was used in western blot on bovine samples (fig 1). Int J Mol Sci (2015) ncbi
mouse monoclonal (A-4)
  • western blot; human; fig 6
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, sc-365513) was used in western blot on human samples (fig 6). Cell Death Dis (2015) ncbi
mouse monoclonal (2A4)
  • western blot; human; loading ...; fig 4b
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, 2A4) was used in western blot on human samples (fig 4b). PLoS ONE (2015) ncbi
mouse monoclonal (2A4)
  • western blot; mouse; fig 7
In order to demonstrate that mTORC1 activation downregulates the CDK8-CycC complex and elevates lipogenic protein expression, Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, SC-13551) was used in western blot on mouse samples (fig 7). PLoS ONE (2015) ncbi
mouse monoclonal (2A4)
  • western blot; mouse; fig 2
  • western blot; human; fig 2
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, sc-13551) was used in western blot on mouse samples (fig 2) and in western blot on human samples (fig 2). Oncogene (2016) ncbi
mouse monoclonal (2A4)
  • western blot; human; fig s7
Santa Cruz Biotechnology SREBP-1 antibody (santa Cruz, sc-13551) was used in western blot on human samples (fig s7). PLoS Genet (2015) ncbi
mouse monoclonal (2A4)
  • western blot; human; 1:500
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz Biotechnology, sc-13551) was used in western blot on human samples at 1:500. Cell Biochem Funct (2014) ncbi
mouse monoclonal (2A4)
  • western blot; human; loading ...; fig s2b
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, 2A4) was used in western blot on human samples (fig s2b). Mol Endocrinol (2014) ncbi
mouse monoclonal (2A4)
  • western blot; human
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz, 2A4) was used in western blot on human samples . J Biochem (2014) ncbi
mouse monoclonal (E-4)
  • western blot; human; 1:200
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz Biotechnology, sc17755) was used in western blot on human samples at 1:200. Biochem Biophys Res Commun (2013) ncbi
mouse monoclonal (2A4)
  • western blot; human
Santa Cruz Biotechnology SREBP-1 antibody (Santa Cruz Biotechnology, 2A4) was used in western blot on human samples . Proc Natl Acad Sci U S A (2005) ncbi
Abcam
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 5f
Abcam SREBP-1 antibody (Abcam, ab191857) was used in western blot on human samples at 1:1000 (fig 5f). Biomed Res Int (2021) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:200; loading ...; fig 1a
  • western blot; human; loading ...; fig 5f, 6a
Abcam SREBP-1 antibody (Abcam, ab191857) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 1a) and in western blot on human samples (fig 5f, 6a). Cell Death Dis (2021) ncbi
domestic rabbit polyclonal
  • western blot; rat; 1:200; loading ...; fig 5a
Abcam SREBP-1 antibody (abcam, ab28481) was used in western blot on rat samples at 1:200 (fig 5a). Aging (Albany NY) (2021) ncbi
domestic rabbit polyclonal
  • western blot; human; fig s8c, s8d
  • western blot; mouse; loading ...; fig s8b
Abcam SREBP-1 antibody (Abcam, ab28481) was used in western blot on human samples (fig s8c, s8d) and in western blot on mouse samples (fig s8b). Hepatology (2018) ncbi
domestic rabbit polyclonal
  • western blot; mouse; 1:1000; loading ...; fig 6a
Abcam SREBP-1 antibody (Cell Signaling, ab28481) was used in western blot on mouse samples at 1:1000 (fig 6a). Int J Mol Med (2018) ncbi
domestic rabbit polyclonal
  • immunohistochemistry - frozen section; mouse; 1:200; loading ...; fig 4c
Abcam SREBP-1 antibody (Abcam, ab28481) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 4c). Int J Mol Med (2016) ncbi
Novus Biologicals
mouse monoclonal (2A4)
  • western blot; mouse; 1:1000; loading ...; fig 6b
Novus Biologicals SREBP-1 antibody (Novus Biologicals, NB #600-582) was used in western blot on mouse samples at 1:1000 (fig 6b). Commun Biol (2021) ncbi
mouse monoclonal (2A4)
  • western blot knockout validation; human; 1:1000; loading ...; fig 1c
Novus Biologicals SREBP-1 antibody (Novus, NB600-582) was used in western blot knockout validation on human samples at 1:1000 (fig 1c). Front Pharmacol (2019) ncbi
mouse monoclonal (2A4)
  • western blot; human; loading ...; fig 1g
In order to demonstrate that RIDalpha utilizes ORP1L to fine-tune lipid raft cholesterol during adenovirus infection, Novus Biologicals SREBP-1 antibody (Novus Biologicals, NB600-582) was used in western blot on human samples (fig 1g). J Virol (2017) ncbi
mouse monoclonal (2A4)
  • western blot; mouse
Novus Biologicals SREBP-1 antibody (Novus Biologicals, NB600-582) was used in western blot on mouse samples . J Lipids (2013) ncbi
Invitrogen
domestic rabbit polyclonal
  • western blot; rat; 1:1000; loading ...; fig 5c
Invitrogen SREBP-1 antibody (Thermo Fisher Scientific, PA1-337) was used in western blot on rat samples at 1:1000 (fig 5c). Mol Med Rep (2021) ncbi
mouse monoclonal (2A4)
  • western blot; mouse; loading ...; fig 6d
In order to assess cyclic alterations of lipid metabolism over a 24-hour period after binge in small heterodimer partner nuclear receptor knockout mice, Invitrogen SREBP-1 antibody (Thermo Fisher, MA5- 11685) was used in western blot on mouse samples (fig 6d). Am J Pathol (2016) ncbi
mouse monoclonal (2A4)
  • western blot; mouse; loading ...; fig 2b
In order to describe the ubiquitination and degradation of liver X receptor, Invitrogen SREBP-1 antibody (Thermo Fischer Scientific, 2A4) was used in western blot on mouse samples (fig 2b). Nature (2016) ncbi
Active Motif
mouse monoclonal (IgG-2A4)
  • western blot; mouse; 1:1000; fig 5
In order to report a role for p53 in regulating the membrane phospholipids composition, Active Motif SREBP-1 antibody (Active Motif, 39939) was used in western blot on mouse samples at 1:1000 (fig 5). Oncotarget (2015) ncbi
mouse monoclonal (IgG-2A4)
  • western blot; human; 1:25
Active Motif SREBP-1 antibody (Active Motif, 39939) was used in western blot on human samples at 1:25. PLoS ONE (2014) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology SREBP-1 antibody (CST, 9874) was used in western blot on human samples (fig 4f). Sci Adv (2020) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 8b
Cell Signaling Technology SREBP-1 antibody (Cell Signaling, 9874) was used in western blot on human samples at 1:1000 (fig 8b). Toxicol Appl Pharmacol (2017) ncbi
domestic rabbit polyclonal
  • western blot; human; loading ...; fig 4f
Cell Signaling Technology SREBP-1 antibody (CST, 9874S) was used in western blot on human samples (fig 4f). Nature (2017) ncbi
BD Biosciences
mouse monoclonal (IgG-2A4)
  • western blot; human; loading ...; fig 1f
BD Biosciences SREBP-1 antibody (BD Biosciences, 557036) was used in western blot on human samples (fig 1f). Cell (2020) ncbi
mouse monoclonal (IgG-2A4)
  • western blot; human; loading ...; fig s9d
BD Biosciences SREBP-1 antibody (BD, 557036) was used in western blot on human samples (fig s9d). Nature (2017) ncbi
mouse monoclonal (IgG-2A4)
  • western blot; mouse; loading ...; fig 1c
In order to investigate the contribution of liver receptor homolog 1 SUMOylation to nonalcoholic fatty liver disease development, BD Biosciences SREBP-1 antibody (BD Biosciences, 557036) was used in western blot on mouse samples (fig 1c). J Clin Invest (2017) ncbi
mouse monoclonal (IgG-2A4)
  • western blot knockout validation; mouse; 1:1000; fig s6
BD Biosciences SREBP-1 antibody (BD Biosciences, 557036) was used in western blot knockout validation on mouse samples at 1:1000 (fig s6). Nat Commun (2016) ncbi
mouse monoclonal (IgG-2A4)
  • western blot; human; fig 3k
In order to find strategies to suppress glioblastoma growth via sterol regulatory element-binding protein-1 inhibition, BD Biosciences SREBP-1 antibody (BD, 557036) was used in western blot on human samples (fig 3k). Clin Cancer Res (2016) ncbi
mouse monoclonal (IgG-2A4)
  • western blot; human; loading ...; fig 7c
BD Biosciences SREBP-1 antibody (BD Technologies, 557036) was used in western blot on human samples (fig 7c). BMC Cancer (2015) ncbi
MilliporeSigma
domestic rabbit polyclonal
  • immunocytochemistry; human; loading ...; fig 8b
  • western blot; human; loading ...; fig 8a
In order to present the trophic and modulatory potential of statins in a dopaminergic cell line, MilliporeSigma SREBP-1 antibody (Sigma-Aldrich, SAB4502850) was used in immunocytochemistry on human samples (fig 8b) and in western blot on human samples (fig 8a). Synapse (2016) ncbi
Articles Reviewed
  1. Han H, Kim S, Kim Y, Jang S, Kwon Y, Choi D, et al. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease. Mol Metab. 2022;55:101402 pubmed publisher
  2. Zhao Y, Li W, Zhang D. Gycyrrhizic acid alleviates atherosclerotic lesions in rats with diabetes mellitus. Mol Med Rep. 2021;24: pubmed publisher
  3. Xu L, Zhang X, Xin Y, Ma J, Yang C, Zhang X, et al. Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway. Cell Death Dis. 2021;12:710 pubmed publisher
  4. Lin Y, Wu X, Zheng C, Zhang Q, Zhang G, Chen K, et al. Mechanistic Investigation on the Regulation of FABP1 by the IL-6/miR-603 Signaling in the Pathogenesis of Hepatocellular Carcinoma. Biomed Res Int. 2021;2021:8579658 pubmed publisher
  5. Li L, Yang L, Yang F, Zhao X, Xue S, Gong F. Ginkgo biloba Extract 50 (GBE50) Ameliorates Insulin Resistance, Hepatic Steatosis and Liver Injury in High Fat Diet-Fed Mice. J Inflamm Res. 2021;14:1959-1971 pubmed publisher
  6. Ma X, Zhao T, Yan H, Guo K, Liu Z, Wei L, et al. Fatostatin reverses progesterone resistance by inhibiting the SREBP1-NF-κB pathway in endometrial carcinoma. Cell Death Dis. 2021;12:544 pubmed publisher
  7. Ma N, Wang Y, Xu S, Ni Q, Zheng Q, Zhu B, et al. PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling. Nat Commun. 2021;12:3059 pubmed publisher
  8. Luo L, Wu J, Lin T, Lian G, Wang H, Gao G, et al. Influence of atorvastatin on metabolic pattern of rats with pulmonary hypertension. Aging (Albany NY). 2021;13:11954-11968 pubmed publisher
  9. Zhang M, Ceyhan Y, Kaftanovskaya E, Vasquez J, Vacher J, Knop F, et al. INPP4B protects from metabolic syndrome and associated disorders. Commun Biol. 2021;4:416 pubmed publisher
  10. Koundouros N, Karali E, Tripp A, Valle A, Inglese P, Perry N, et al. Metabolic Fingerprinting Links Oncogenic PIK3CA with Enhanced Arachidonic Acid-Derived Eicosanoids. Cell. 2020;181:1596-1611.e27 pubmed publisher
  11. Park E, Yu T, Yang K, Choi S, Lee S, Park K. Cube natural sea salt ameliorates obesity in high fat diet-induced obese mice and 3T3-L1 adipocytes. Sci Rep. 2020;10:3407 pubmed publisher
  12. Aldonza M, Ku J, Hong J, Kim D, Yu S, Lee M, et al. Prior acquired resistance to paclitaxel relays diverse EGFR-targeted therapy persistence mechanisms. Sci Adv. 2020;6:eaav7416 pubmed publisher
  13. Yang S, Ma C, Wu H, Zhang H, Yuan F, Yang G, et al. Tectorigenin attenuates diabetic nephropathy by improving vascular endothelium dysfunction through activating AdipoR1/2 pathway. Pharmacol Res. 2020;153:104678 pubmed publisher
  14. Yang N, Li C, Li H, Liu M, Cai X, Cao F, et al. Emodin Induced SREBP1-Dependent and SREBP1-Independent Apoptosis in Hepatocellular Carcinoma Cells. Front Pharmacol. 2019;10:709 pubmed publisher
  15. Su L, Zhou L, Chen F, Wang H, Qian H, Sheng Y, et al. Cideb controls sterol-regulated ER export of SREBP/SCAP by promoting cargo loading at ER exit sites. EMBO J. 2019;38: pubmed publisher
  16. Nakazeki F, Tsuge I, Horie T, Imamura K, Tsukita K, Hotta A, et al. MiR-33a is a therapeutic target in SPG4-related hereditary spastic paraplegia human neurons. Clin Sci (Lond). 2019;133:583-595 pubmed publisher
  17. Wang Y, Du L, Liang X, Meng P, Bi L, Wang Y, et al. Sirtuin 4 Depletion Promotes Hepatocellular Carcinoma Tumorigenesis Through Regulating Adenosine-Monophosphate-Activated Protein Kinase Alpha/Mammalian Target of Rapamycin Axis in Mice. Hepatology. 2018;: pubmed publisher
  18. Guo J, Fang W, Chen X, Lin Y, Hu G, Wei J, et al. Upstream stimulating factor 1 suppresses autophagy and hepatic lipid droplet catabolism by activating mTOR. FEBS Lett. 2018;592:2725-2738 pubmed publisher
  19. Song H, Li X, Liu Y, Lu W, Cui Z, Zhou L, et al. Carnosic acid protects mice from high-fat diet-induced NAFLD by regulating MARCKS. Int J Mol Med. 2018;42:193-207 pubmed publisher
  20. Bai X, Hong W, Cai P, Chen Y, Xu C, Cao D, et al. Valproate induced hepatic steatosis by enhanced fatty acid uptake and triglyceride synthesis. Toxicol Appl Pharmacol. 2017;324:12-25 pubmed publisher
  21. Dey P, Baddour J, Muller F, Wu C, Wang H, Liao W, et al. Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer. Nature. 2017;542:119-123 pubmed publisher
  22. Stein S, Lemos V, Xu P, Demagny H, Wang X, Ryu D, et al. Impaired SUMOylation of nuclear receptor LRH-1 promotes nonalcoholic fatty liver disease. J Clin Invest. 2017;127:583-592 pubmed publisher
  23. Cianciola N, Chung S, Manor D, Carlin C. Adenovirus Modulates Toll-Like Receptor 4 Signaling by Reprogramming ORP1L-VAP Protein Contacts for Cholesterol Transport from Endosomes to the Endoplasmic Reticulum. J Virol. 2017;91: pubmed publisher
  24. Kong Q, Zhang H, Zhao T, Zhang W, Yan M, Dong X, et al. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice. Int J Mol Med. 2016;38:1715-1726 pubmed publisher
  25. Yang Z, Tsuchiya H, Zhang Y, Lee S, Liu C, Huang Y, et al. REV-ERB? Activates C/EBP Homologous Protein to Control Small Heterodimer Partner-Mediated Oscillation of Alcoholic Fatty Liver. Am J Pathol. 2016;186:2909-2920 pubmed publisher
  26. Jang H, Lee G, Selby C, Lee G, Jeon Y, Lee J, et al. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding. Nat Commun. 2016;7:12180 pubmed publisher
  27. Hsieh J, Koseki M, Molusky M, Yakushiji E, Ichi I, Westerterp M, et al. TTC39B deficiency stabilizes LXR reducing both atherosclerosis and steatohepatitis. Nature. 2016;535:303-7 pubmed publisher
  28. Geng F, Cheng X, Wu X, Yoo J, Cheng C, Guo J, et al. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis. Clin Cancer Res. 2016;22:5337-5348 pubmed
  29. Tong X, Li P, Zhang D, VanDommelen K, Gupta N, Rui L, et al. E4BP4 is an insulin-induced stabilizer of nuclear SREBP-1c and promotes SREBP-1c-mediated lipogenesis. J Lipid Res. 2016;57:1219-30 pubmed publisher
  30. Yan C, Chen J, Chen N. Long noncoding RNA MALAT1 promotes hepatic steatosis and insulin resistance by increasing nuclear SREBP-1c protein stability. Sci Rep. 2016;6:22640 pubmed publisher
  31. Schmitt M, Dehay B, Bezard E, Garcia Ladona F. Harnessing the trophic and modulatory potential of statins in a dopaminergic cell line. Synapse. 2016;70:71-86 pubmed publisher
  32. Ao J, Wei C, Si Y, Luo C, Lv W, Lin Y, et al. Tudor-SN Regulates Milk Synthesis and Proliferation of Bovine Mammary Epithelial Cells. Int J Mol Sci. 2015;16:29936-47 pubmed publisher
  33. Laezza C, D Alessandro A, Di Croce L, Picardi P, Ciaglia E, Pisanti S, et al. p53 regulates the mevalonate pathway in human glioblastoma multiforme. Cell Death Dis. 2015;6:e1909 pubmed publisher
  34. Ochiai A, Miyata S, Shimizu M, Inoue J, Sato R. Piperine Induces Hepatic Low-Density Lipoprotein Receptor Expression through Proteolytic Activation of Sterol Regulatory Element-Binding Proteins. PLoS ONE. 2015;10:e0139799 pubmed publisher
  35. Rueda Rincon N, Bloch K, Derua R, Vyas R, Harms A, Hankemeier T, et al. p53 attenuates AKT signaling by modulating membrane phospholipid composition. Oncotarget. 2015;6:21240-54 pubmed
  36. Feng D, Youn D, Zhao X, Gao Y, Quinn W, Xiaoli A, et al. mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC). PLoS ONE. 2015;10:e0126240 pubmed publisher
  37. Belkaid A, Duguay S, Ouellette R, Surette M. 17β-estradiol induces stearoyl-CoA desaturase-1 expression in estrogen receptor-positive breast cancer cells. BMC Cancer. 2015;15:440 pubmed publisher
  38. Li S, Oh Y, Yue P, Khuri F, Sun S. Inhibition of mTOR complex 2 induces GSK3/FBXW7-dependent degradation of sterol regulatory element-binding protein 1 (SREBP1) and suppresses lipogenesis in cancer cells. Oncogene. 2016;35:642-50 pubmed publisher
  39. Kirschner K, Samarajiwa S, Cairns J, Menon S, Perez Mancera P, Tomimatsu K, et al. Phenotype specific analyses reveal distinct regulatory mechanism for chronically activated p53. PLoS Genet. 2015;11:e1005053 pubmed publisher
  40. Caputo M, De Rosa M, Rescigno T, Zirpoli H, Vassallo A, De Tommasi N, et al. Binding of polyunsaturated fatty acids to LXRα and modulation of SREBP-1 interaction with a specific SCD1 promoter element. Cell Biochem Funct. 2014;32:637-46 pubmed publisher
  41. Daniëls V, Smans K, Royaux I, Chypre M, Swinnen J, Zaidi N. Cancer cells differentially activate and thrive on de novo lipid synthesis pathways in a low-lipid environment. PLoS ONE. 2014;9:e106913 pubmed publisher
  42. Wang Y, Zhou D, Chen S. SGK3 is an androgen-inducible kinase promoting prostate cancer cell proliferation through activation of p70 S6 kinase and up-regulation of cyclin D1. Mol Endocrinol. 2014;28:935-48 pubmed publisher
  43. Nakakuki M, Kawano H, Notsu T, Imada K, Mizuguchi K, Shimano H. A novel processing system of sterol regulatory element-binding protein-1c regulated by polyunsaturated fatty acid. J Biochem. 2014;155:301-13 pubmed publisher
  44. Yoshida G, Saya H, Zouboulis C. Three-dimensional culture of sebaceous gland cells revealing the role of prostaglandin E2-induced activation of canonical Wnt signaling. Biochem Biophys Res Commun. 2013;438:640-6 pubmed publisher
  45. Wen S, Jadhav K, Williamson D, Rideout T. Treadmill Exercise Training Modulates Hepatic Cholesterol Metabolism and Circulating PCSK9 Concentration in High-Fat-Fed Mice. J Lipids. 2013;2013:908048 pubmed publisher
  46. Bengoechea Alonso M, Punga T, Ericsson J. Hyperphosphorylation regulates the activity of SREBP1 during mitosis. Proc Natl Acad Sci U S A. 2005;102:11681-6 pubmed